日本道一区二区更新免费,国产欧美久久久精品影院,国产成人处女AⅤ一区二区,91色色色,精品国产一区二区三区香蕉网址,熟女偷情自拍,国产成人久久77777精品 ,欧美一区二区三区男人的天堂,久久99国产精品久久99蜜桃,四虎精品一区二区免费

About Hasten
ROOTED IN CHINA, THINKING GLOBALLY

Scroll down

ABOUT HASTEN BIOPHARMACEUTICAL CO., LTD

Hasten Biopharmaceutical Co., Ltd.(Hasten), which integrates R&D, production and commercialization and covers the whole industrial chain, was established in 2020. Hasten is jointly invested and established by CBC Group, Hefei Industry Investment Group and Feidong County, Hefei City. In April, 2023, Hasten received a US$315 million fundraising round co-led by CBC and Abu Dhabi sovereign wealth fund, Mubadala Investment Company, with participation from other institutional investors. Proceeds will be used to fund future acquisitions and business development of innovative pipeline assets.

We are committed to becoming a leader in the healthcare industry. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases & critical care related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients and create social value.

  • 2 overseas wholly-owned subsidiaries
  • 1 production base
  • 8 countries and regions in Pan-Asia,
    mainland China & Switzerland patients benefited

OUR CULTURE

  • VISION
    VISION

    We are committed to becoming a leader in the healthcare industry that is trusted by customers, recognized by employees, and respected by society

  • MISSION
    MISSION

    Invest in science and talents,

    continue to leverage 

    commercialization advantages,

    provide high-quality medicines and 

    solutions that improve lives of people 

    and create social value.

  • VALUE
    VALUE

    Integrity

    Agility

    Innovation

    Ownership

  • AMBITIONS
    AMBITIONS

    In the future, the unmet medical needs in the fields of chronic diseases and critical care related diseases will be growing and generate large marketing potentials.

    Rooted in China with a global perspective, Hasten will connect the upstream and downstream industrial chains through the layout of "whole industry" and "globalization". We will enrich product structure and pipelines in diversified ways and rely on the broad medical and health platform and resources of CBC Group, as well as invest in science and talents to continuously leverage commercialization advantages.

    We are committed to becoming a leader in the healthcare industry. We will work closely with our stakeholders such as relevant government institutions, medical and health professionals and industry partners to continuously drive the management ecosystem of chronic diseases & critical care related diseases, aiming to build a leading innovative medical and healthcare enterprise in China so as to benefit more patients and create social value.

公司地址：這里是公司地址后期需要替換設計占位后臺可替換

企業(yè)郵箱：infu@singlera.com.cn

聯(lián)系電話：+86-8888-8888

商務聯(lián)系：BD@singlera.com.cn

人力資源：HR@singlera.com.cn

×